MENU
+Compare
GTBP
Stock ticker: NASDAQ
AS OF
Dec 20 closing price
Price
$1.75
Change
-$0.17 (-8.85%)
Capitalization
3.95M

GTBP GT Biopharma Forecast, Technical & Fundamental Analysis

Industry Biotechnology
GTBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for GTBP with price predictions
Dec 20, 2024

Momentum Indicator for GTBP turns negative, indicating new downward trend

GTBP saw its Momentum Indicator move below the 0 level on December 11, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 113 similar instances where the indicator turned negative. In of the 113 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

GTBP moved below its 50-day moving average on December 13, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for GTBP crossed bearishly below the 50-day moving average on December 13, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GTBP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GTBP entered a downward trend on December 18, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where GTBP advanced for three days, in of 227 cases, the price rose further within the following month. The odds of a continued upward trend are .

GTBP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.860) is normal, around the industry mean (14.556). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). GTBP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (256.215).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. GTBP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GTBP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
GTBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GTBP is expected to report earnings to rise 41.67% to -8 cents per share on March 27

GT Biopharma GTBP Stock Earnings Reports
Q4'23
Est.
$-0.09
Q3'23
Beat
by $0.03
Q2'23
Beat
by $0.05
Q1'23
Beat
by $0.16
Q4'22
Missed
by $0.01
The last earnings report on November 01 showed earnings per share of -5 cents, beating the estimate of -9 cents. With 86.83K shares outstanding, the current market capitalization sits at 3.95M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
8000 Marina Boulevard
Phone
+1 415 919-4040
Employees
2
Web
https://www.gtbiopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNA10.081.34
+15.33%
Ginkgo Bioworks Holdings
SONO14.560.15
+1.04%
Sonos
DOX87.010.86
+1.00%
Amdocs Limited
LUCY5.70-0.20
-3.39%
Innovative Eyewear Inc.
SPWH2.29-0.12
-4.98%
Sportsman's Warehouse Holdings

GTBP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBP has been loosely correlated with PTCT. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GTBP jumps, then PTCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTBP
1D Price
Change %
GTBP100%
-9.11%
PTCT - GTBP
35%
Loosely correlated
+2.19%
AMRN - GTBP
33%
Poorly correlated
-1.18%
MDGL - GTBP
32%
Poorly correlated
+5.12%
VKTX - GTBP
31%
Poorly correlated
+1.83%
BPMUF - GTBP
29%
Poorly correlated
N/A
More